EichorEICHOR
Condition: Brain Tumor Adult Glioblastoma Synced from ClinicalTrials.gov · August 09, 2026

Recruiting studies: Brain Tumor Adult Glioblastoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Phase N/A · 8 location(s) · Erasmus Medical Center · NCT06273176Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Phase 2 · 2 location(s) · Baptist Health South Florida · NCT06991101Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
Phase N/A · 1 location(s) · Medical University of Warsaw · NCT07411690Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared
Phase 3 · 1 location(s) · Northwell Health · NCT05271240IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
Phase 1 · 1 location(s) · University of Florida · NCT05353530Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transde
NA · 1 location(s) · Medical University of Warsaw · NCT07413796Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
NA · 1 location(s) · Northwell Health · NCT05954858Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Phase N/A · 54 location(s) · GT Medical Technologies, Inc. · NCT04427384The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06118723The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06283927Hypofractionated Radiotherapy
NA · 1 location(s) · The First Hospital of Jilin University · NCT06740955Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Phase 1 · 1 location(s) · Jazz Pharmaceuticals · NCT04541082A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubbl
Phase 3 · 2 location(s) · NaviFUS Corporation · NCT06496971DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Phase 2 · 18 location(s) · Diakonos Oncology Corporation · NCT06805305Study of Olutasidenib and Temozolomide in HGG
Phase 2 · 20 location(s) · Rigel Pharmaceuticals · NCT06161974RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
Phase 1 · 1 location(s) · University of Florida · NCT06389591Key Longitudinal Associations With Risk and Glioblastoma Outcomes
Phase N/A · 1 location(s) · Duke University · NCT06625684RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
Phase 1 · 1 location(s) · University of Florida · NCT07492316The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06146725A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Gliobl
Phase 1 · 2 location(s) · University of Florida · NCT04573140A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the S
Phase 1 · 1 location(s) · University College, London · NCT07134842Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Phase 2 · 20 location(s) · Nationwide Children's Hospital · NCT05843253Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Phase 1/Phase 2 · 7 location(s) · Neonc Technologies, Inc. · NCT06047379Targeted Pediatric High-Grade Glioma Therapy
Phase N/A · 21 location(s) · Nationwide Children's Hospital · NCT05839379A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Phase 1 · 3 location(s) · Tetragon Biosciences Ltd · NCT07464925Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard
Phase 1 · 1 location(s) · Sunnybrook Health Sciences Centre · NCT07179328Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastom
Phase 3 · 4 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT07100730Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
Phase 1/Phase 2 · 1 location(s) · Northwell Health · NCT03213002
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.